Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

HIV-TB coinfection: Clinico-epidemiological determinants at an antiretroviral therapy center in Southern India.

Kamath R, Sharma V, Pattanshetty S, Hegde MB, Chandrasekaran V.

Lung India. 2013 Oct;30(4):302-6. doi: 10.4103/0970-2113.120605.

2.

Efficacy of a new model for delivering integrated TB and HIV services for people living with HIV/AIDS in Delhi -- case for a paradigm shift in national HIV/TB cross-referral strategy.

Gupta AK, Singh GP, Goel S, Kaushik PB, Joshi BC, Chakraborty S.

AIDS Care. 2014 Feb;26(2):137-41. doi: 10.1080/09540121.2013.808734. Epub 2013 Jun 19.

PMID:
24364397
3.

Current scenario of opportunistic and co-infections in HIV-infected individuals at a tertiary care hospital in Mumbai, India.

Chavan VR, Chaudhary V, Ahir P, Mehta R, Mavani PS, Kerkar C, Pramanik JM.

Indian J Med Microbiol. 2015 Jan-Mar;33(1):78-83. doi: 10.4103/0255-0857.148386.

4.

Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?

Lawn SD, Harries AD, Williams BG, Chaisson RE, Losina E, De Cock KM, Wood R.

Int J Tuberc Lung Dis. 2011 May;15(5):571-81. doi: 10.5588/ijtld.10.0483.

5.

Proportion and determinants of tuberculosis among human immunodeficiency virus-positive patients attending the antiretroviral therapy center attached to a Medical College in South India.

Hiregoudar V, Raghavendra B, Karinagannavar A, Khan W, Kamble S, Goud TG.

J Family Community Med. 2016 May-Aug;23(2):88-93. doi: 10.4103/2230-8229.181009.

6.

TB treatment outcomes among TB-HIV co-infections in Karnataka, India: how do these compare with non-HIV tuberculosis outcomes in the province?

Shastri S, Naik B, Shet A, Rewari B, De Costa A.

BMC Public Health. 2013 Sep 11;13:838. doi: 10.1186/1471-2458-13-838.

7.

Successful Tuberculosis Treatment Outcomes among HIV/TB Coinfected Patients Down-Referred from a District Hospital to Primary Health Clinics in Rural South Africa.

Jacobson KB, Moll AP, Friedland GH, Shenoi SV.

PLoS One. 2015 May 19;10(5):e0127024. doi: 10.1371/journal.pone.0127024. eCollection 2015.

9.

Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India.

Alvarez-Uria G, Pakam R, Midde M, Naik PK.

J Int AIDS Soc. 2014 Dec 9;17:19251. doi: 10.7448/IAS.17.1.19251. eCollection 2014.

10.

Epidemiological Characteristics and Clinical Outcome of HIV-Related Tuberculosis in a Population of TB Patients in South-western Nigeria.

Olowe OA, Makanjuola OB, Adekanmi AS, Adefioye OJ, Olowe RA.

Eur J Microbiol Immunol (Bp). 2017 Apr 26;7(2):127-132. doi: 10.1556/1886.2017.00003. eCollection 2017 Jun.

11.

Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study.

Sileshi B, Deyessa N, Girma B, Melese M, Suarez P.

BMC Infect Dis. 2013 Jul 1;13:297. doi: 10.1186/1471-2334-13-297.

12.

Healthcare provision for HIV co-infected tuberculosis patients in rural Zambia: an observational cohort study at primary care centers.

Miyano S, Muvuma S, Ishikawa N, Endo H, Msiska C, Syakantu G.

BMC Health Serv Res. 2013 Oct 8;13:397. doi: 10.1186/1472-6963-13-397.

13.

Integrated therapy for HIV and tuberculosis.

Manosuthi W, Wiboonchutikul S, Sungkanuparph S.

AIDS Res Ther. 2016 May 12;13:22. doi: 10.1186/s12981-016-0106-y. eCollection 2016. Review.

15.

HIV testing, antiretroviral therapy, and treatment outcomes in new cases of tuberculosis in Brazil, 2011.

Torrens A, Bartholomay P, Silva S, Khogali M, Verdonck K, Bissell K.

Rev Panam Salud Publica. 2016 Jan;39(1):26-31.

16.

Feasibility of provider-initiated HIV testing and counselling of tuberculosis patients under the TB control programme in two districts of South India.

Vijay S, Swaminathan S, Vaidyanathan P, Thomas A, Chauhan LS, Kumar P, Chiddarwar S, Thomas B, Dewan PK.

PLoS One. 2009 Nov 19;4(11):e7899. doi: 10.1371/journal.pone.0007899.

17.

Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database.

Han SH, Zhou J, Lee MP, Zhao H, Chen YM, Kumarasamy N, Pujari S, Lee C, Omar SF, Ditangco R, Phanuphak N, Kiertiburanakul S, Chaiwarith R, Merati TP, Yunihastuti E, Tanuma J, Saphonn V, Sohn AH, Choi JY; TREAT Asia HIV Observational Database.

HIV Med. 2014 Feb;15(2):77-85. doi: 10.1111/hiv.12073. Epub 2013 Aug 28.

18.

Outcomes and impact of HIV prevention, ART and TB programs in Swaziland--early evidence from public health triangulation.

van Schalkwyk C, Mndzebele S, Hlophe T, Garcia Calleja JM, Korenromp EL, Stoneburner R, Pervilhac C.

PLoS One. 2013 Jul 26;8(7):e69437. doi: 10.1371/journal.pone.0069437. Print 2013.

20.

Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.

Ravimohan S, Tamuhla N, Steenhoff AP, Letlhogile R, Nfanyana K, Bellamy SL, MacGregor RR, Gross R, Weissman D, Bisson GP.

Lancet Infect Dis. 2015 Apr;15(4):429-38. doi: 10.1016/S1473-3099(15)70008-3. Epub 2015 Feb 9. Erratum in: Lancet Infect Dis. 2015 May;15(5):505.

Supplemental Content

Support Center